Southern Research has supported preclinical pharmacological and toxicological studies for government and commercial clients for more than 80 years. These efforts have resulted in the development of a highly talented, experienced, and dedicated staff of scientists with expertise in executing a broad range of studies to support Investigational New Drug (IND)-enabling programs. In addition, we operate in full compliance with U.S. FDA GLP regulations.
To ensure high-quality study execution and client satisfaction, our team of scientists and technical staff work as an extension of your team to provide a level of partnership that is unparalleled among contract research organizations.

Southern Research Institute offers
Therapeutic Discovery
Hit Identification
Hit-to-lead Optimization
Discovery ADME,
Bioanalytical Informatics
Medicinal Chemistry Support
Immunophenotyping
Functional Assays
Customized Assays
GLP Toxicology
Efficacy Studies (BSL-3 Capabilities)
Tumor Xenograft Models
IND-Enabling Studies in Rodent to NHP Animal Models